Author:
Gounder Murugesan K.,Nazar Ahamed S.,Saleem Ahamed,Pungaliya Pooja,Kulkarni Diptee,Versace Richard,Rubin Eric H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference29 articles.
1. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Ann Rev Biochem 58:351–375
2. Natelson EA, Giovanella BC, Verschraegen CF, Fehir KM, De Ipolyi PD, Harris N, Sthelin JS (1996) Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents. Ann NY Acad Sci 803:224–230
3. Hsiang Y, Lihou M, Liu LF (1989) Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077–5082
4. Reid RJ, Benedetti P, Bjornsti MA (1998) Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. Biochim Biophys Acta 1400:289–300
5. Rubin E, Pantazis P, Bharti A, Toppmeyer D, Giovanella BC, Kufe D (1994) Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J Biol Chem 269:2433–2439
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献